Vivos Therapeutics, Inc. VVOS 深 滬
已收盤 09-19 16:00:00 美东时间
3.22
-0.910
-22.03%
華盛通- 最 高3.29
- 今 開3.28
- 成交量 364.98万股
- 最 低 2.93
- 昨 收 4.13
- 總市值 9637.07万
- 52周最高 48.79
- 市盈率 靜 --
- 換手率 12.20%
- 52周最低 1.91
- 委 比 60.00%
- 總股本 2992.88万
- 歷史最高 360.25
- 量 比 0.25
- 振 幅 8.72%
- 歷史最低 1.91
- 每 手 1
- 風險率 4.08%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Why Vivos Therapeutics (VVOS) Stock Is Down 25% Today
Vivos Therapeutics shares are trading lower by 25% Thursday morning. The company announced a $4.3 million registered offering.
09-19 22:37
Vivos Therapeutics announces $4.3M registered direct offering of common stock
Vivos Therapeutics (NASDAQ:VVOS) has entered into agreement for direct offering of an aggregate of 1.36M common shares at $3.15 per share for gross proceeds of ~$4.3M Closing date is September 20. The...
09-19 19:53
美股牛股 | 多家医药公司股价飙升，APLT飙升近70%，VVOS涨近50%
多家医药公司股价飙升，APLT飙升近70%，VVOS涨近50%；太空概念股LUNR暴涨38%，获NASA48.2亿美元的“近空间网络”合同>>
09-19 18:45
Vivos Therapeutics Enhances Incentives and Executive Pay Structure
The latest announcement is out from Vivos Therapeutics ( ($VVOS) ). Vivos Thera...
09-13 05:29
Ascendiant Capital Maintains Buy on Vivos Therapeutics, Raises Price Target to $6.6
Ascendiant Capital analyst Lucas Ward maintains Vivos Therapeutics (NASDAQ:VVOS) with a Buy and raises the price target from $6.4 to $6.6.
08-20 17:33
Vivos Therapeutics Analyst Ratings
Unity Software(U.US) reported fourth-quarter financial results after the market...
08-20 17:30
快讯 | vivos therapeutics第二季度毛利润265.1万美元
Vivos Therapeutics Q2 Gross Profit USD 2.651 Million
08-15 04:05
快讯 | vivos therapeutics报告了2024年第二季度财务业绩，并提供了运营更新。
Vivos Therapeutics Reports Second Quarter 2024 Financial Results and Provides O...
08-15 04:05
快讯 | vivos therapeutics第二季度营业费用458.7万美元
Vivos Therapeutics Q2 Operating Expenses USD 4.587 Million
08-15 04:05
